Secondary analysis examines risk factors influenced by fatty acid supplementation in retinopathy of prematurity, suggesting vital clinical insights.
This secondary analysis of a randomized clinical trial examines what risk factors for retinopathy of prematurity are influenced by supplementation with arachidonic acid and docosahexaenoic acid and their interactions with severe retinopathy of prematurity.
No takes yet. Share an insight, caveat, or question.
Lundgren et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: